< Back to latest news & events

Event

“Case Law” epi roadshow – Brussels

March 2019

Event date: 28th March 2019

HGF Partner Leythem Wall will be speaking at the “Case Law” epi roadshow supported by the EPO in Brussels on March 28 2019.

The “Case Law” seminars will provide you with an overview of the most recent key decisions and developments in the EPO’s board of appeal case law.

Organised by the epi with the support of the EPO Boards of the Appeal and the European Patent Academy, the seminar also includes the demonstration of a mock Oral Proceedings.

Leythem Wall will be speaking as an epi expert.

Key topics will include:

  • Disclaimers;
  • Clarity; and
  • Specific applications of the problem-and-solution approach.

Latest updates

Happy World IP Day!

This year’s theme is ‘IP and the SDGs: Building our common future with innovation and creativity’. At HGF we are committed to supporting our clients in sustainable technologies and routinely …

Read article

IP Ingredients, Part 12: Exploring colours in the food & drink sector – overcoming hurdles and leveraging colour trade marks

We will all recognise as consumers an instance of when we used the colour of a product or its packaging to identify a specific brand that we wanted to buy …

Read article

Medical 3D Technologies: From Scanning to Printing

When we think of 3D technologies, we often think of 3D printing, which, as discussed later, has seen rapid advances in recent years. However, a sometimes overlooked area of medical …

Read article

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

Intellectual Property (IP) is a core part of any business and particularly is a vital part of the strategic toolkit for any business that creates value through innovation and constant …

Read article

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article